KLI

Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation

Metadata Downloads
Abstract
Background We assessed the prognostic impact of the ADV score (alpha-fetoprotein [AFP]-des-gamma-carboxyprothrombin [DCP]-tumor volume [TV] score) for predicting hepatocellular carcinoma (HCC) recurrence and patient survival after living donor liver transplantation (LDLT). Methods This study included 843 HCC patients who underwent LDLT between January 2006 and December 2015 at Asan Medical Center. These cases were divided into treatment-naive (TN, n = 256]) and pretransplant-treated (PT, n = 587 [69.6%]) groups. Results There were weak or nearly no correlations among AFP, DCP, and TV. There existed high correlations between the pretransplant and explant findings regarding tumor number, size, and ADV score. Right lobe grafts were implanted in 760 (90.2%) patients. HCC recurrence and all-cause patient death occurred in 182 (15.9%) and 126 (15.0%) respectively during the follow-up period for 75.6 +/- 35.5 months. The 5-year tumor recurrence (TR) and overall patient survival (OS) rates were 21.5% and 86.2%, respectively. The PT group showed higher TR (p < 0.001) and lower OS rates (p < 0.001). TR and OS were closely correlated with both pretransplant and explant ADV scores in the TN and PT groups. The ADV score enabled further prognostic stratification of the patients within and beyond the Milan, UCSF, and Asan Medical Center criteria. Compared with the 7 pre-existing selection criteria, ADV score with a cutoff of 5log showed the highest prognostic contrast regarding TR and OS. Conclusions Our prognostic prediction model using ADV scores is an integrated quantitative surrogate biomarker for posttransplant prognosis in HCC patients and can provide reliable information that assists the decision-making for LDLT.
Author(s)
김기훈문덕복박길춘송기원안철수윤영인이승규정동환하태용황신
Issued Date
2021
Type
Article
Keyword
Hepatocellular carcinomaPredictionPrognosisRecurrenceTumor biology
DOI
10.1007/s11605-021-04939-w
URI
https://oak.ulsan.ac.kr/handle/2021.oak/8552
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_proquest_miscellaneous_2486162602&amp;context=PC&amp;vid=ULSAN&amp;lang=ko_KR&amp;search_scope=default_scope&amp;adaptor=primo_central_multiple_fe&amp;tab=default_tab&amp;query=any,contains,Quantitative%20Prognostic%20Prediction%20Using%20ADV%20Score%20for%20Hepatocellular%20Carcinoma%20Following%20Living%20Donor%20Liver%20Transplantation&amp;offset=0&amp;pcAvailability=true
Publisher
JOURNAL OF GASTROINTESTINAL SURGERY
Location
미국
Language
영어
ISSN
1091-255X
Citation Volume
25
Citation Number
10
Citation Start Page
2503
Citation End Page
2515
Appears in Collections:
Medicine > Medicine
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.